The AJMC® clinical page includes all the published content across AJMC.com, The American Journal of Managed Care® and Evidence-Based Oncology™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.
May 2nd 2025
To better treat adolescent and young adult (AYA) patients with various subtypes of Hodgkin and non-Hodgkin lymphomas (NHL), Andrew Evens, DO, speaks to the importance of primary care, screening access, and research.
Study Does Not Find Sufficient Evidence of Medicinal Cannabis Use for Chronic Pain
August 25th 2017Medicinal cannabis has become increasingly accepted in the United States and is commonly used for pain management. Despite its growing popularity as a treatment, there is little evidence available about the harms and benefits of cannabis utilization.
Read More
Gender Differences in the Brain Explain Why Men Have Higher Rates of ADHD
August 24th 2017The brains of women are significantly more active than the brains of men, according to the largest functional brain imaging study to date conducted by Amen Clinics. This explains why there are higher rates of some conditions, such as attention-deficit/hyperactivity disorder (ADHD), in men compared with women, who have higher rates of depression.
Read More
Study Finds HPV Vaccination Underutilized by Childhood Cancer Survivors
August 24th 2017A new study in the Journal of Clinical Oncology identifies an increased role for physicians in boosting human papillomavirus (HPV) vaccination rates among childhood cancer survivors to reduce their risk of a second cancer.
Read More
Probiotics Do Not Have a Significant Impact on Preventing Eczema, Asthma in Infants
August 23rd 2017Probiotics are often believed to stimulate healthy immune function, but a new study did not find significant evidence that a supplement of lactobacillus prevents eczema, which is a common precursor to asthma.
Read More
Expanded Approval, New Dosage Form for Olaparib in Recurrent Ovarian Cancer
August 18th 2017A new oral dosage form of olaparib (Lynparza) has been approved as maintenance treatment in women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, who are in a complete or partial response to platinum-based chemotherapy.
Read More
ICER: ADF Opioids Not Effective in Reducing Population Opioid Abuse
August 17th 2017The Institute for Clinical and Economic Review (ICER) released a Final Evidence Report that found an absence of sufficient evidence to confirm the efficacy of abuse-deterrent formulations (ADFs) of opioids in decreasing the opioid abuse levels of the greater population.
Read More
Survey Results Suggest Payers, Gastroenterologists Favor JAK Inhibitors to Treat IBD
August 16th 2017Gastroenterologists favorably view Janus kinase (JAK) inhibitors for utilization in treating inflammatory bowel disease (IBD), according to a recent survey conducted by Decision Resources Group.
Read More
COPD Is Overdiagnosed in Hospitalized Patients, Study Finds
August 14th 2017Chronic obstructive pulmonary disease (COPD) is typically diagnosed through a patient history exam and a physical exam; however, because symptoms of COPD-dyspnea, cough, and wheeze-are common symptoms for many other diseases, many patients are misdiagnosed due to the lack of necessary testing performed to confirm the presence of the disease.
Read More
Atopic Dermatitis Creates a Significant Burden on the Quality of Life of Adult Patients
August 11th 2017Atopic dermatitis (AD) presents a significant humanistic burden on the quality of life among adult patients. Due to its public health impact and negative symptoms, the development for new and more effective treatments are necessary.
Read More
ICER Seeks Public Comment on Scoping Document for CAR-T Treatments
August 10th 2017The Institute for Clinical and Economic Review (ICER) has released a draft version of their scoping document that will compare the clinical effectiveness and value of 2 chimeric antigen receptor (CAR)-T cell treatments being reviewed by the FDA.
Read More
Eczema Affects All Ages and New Treatments Could Improve Quality of Life for Patients
August 8th 2017Eczema is often assumed to be a childhood disease; however, the skin condition also affects adults and its prevalence is continually increasing. About half as many adults are affected by eczema than children, but it can negatively influence their quality of life.
Read More
Phase 1 and Phase 2 Study Results Find Potential Treatment for Severe Cystic Fibrosis
August 5th 2017Vertex Pharmaceuticals recently announced positive data from phase 1 and 2 studies of 3 triple combination regimens in cystic fibrosis patients with one F508del mutation and one minimal function mutation (F508del/Min). These results are the first to present the potential of treating the underlying cause of those with difficult-to-treat cystic fibrosis.
Read More
Study Identifies 5 Key Values of Quality Care for Patients With Rheumatoid Arthritis
August 5th 2017The idea of quality care for rheumatoid arthritis (RA) often varies among the patient, clinician, and healthcare provider. However, there is a lack of representation of the patient’s perspective involved in the quality indicators that are the current standards for RA outcomes.
Read More
Lung CT Changes in COPD Patients Affects the Human Lung Microbiome
August 2nd 2017There is an association between computed tomography (CT) detectable structural changes in the lungs of patients with chronic obstructive pulmonary disease (COPD) and changes in bacterial communities that influence alterations in the relationship between microbes and host cells, according to a new study published in PLOS One.
Read More